Who are Sequel's investors?

Sequel's investors include FemHealth Ventures, Alumni Ventures, Graph Ventures, Growth Warrior Capital, Javelin Venture Partners, Long Journey Ventures, Social Leverage, Struck Capital and 1 more.

How much funding has Sequel raised?

Sequel has disclosed $8M raised across 1 of its 4 known rounds.

Where is Sequel headquartered?

Sequel is headquartered in Manchester, US.

Sequel

Manchester, US · 13 known investors

Find your way into Sequel

Sequel Med Tech develops wearable insulin delivery devices and precise drug delivery technology for people with diabetes and others, building on the legacy of the insulin pump. The company serves people with type 1 diabetes and healthcare providers, with plans to support drug delivery beyond diabetes.

Digital Health Hardware Healthtech Medical Devices

Investors · 13

FemHealth VenturesShort Hills

Alumni VenturesreportedManchester · $100K – $10M

Graph Venturesreported · 2 sourcesNew York · $5K – $5M

Growth Warrior CapitalreportedCarson City · $1M – $1.5M

Javelin Venture Partnersreported · 2 sourcesSan Francisco · $500K – $4M

Long Journey Venturesreported · 2 sourcesSan Francisco · $100K – $1M

Social LeveragereportedScottsdale · $1M – $2M

Struck CapitalreportedLos Angeles · $500K – $2M

Ulu Venturesreported · 2 sourcesPalo Alto · $2M

Also in the syndicate · 4

Great OaksMaC VCPear AcceleratorV1VC

Funding

SEC filings, press & company announcements

$8M disclosed across 1 of 4 rounds · 2021–2022

Undisclosed amountSeries ASep 2022
Source ↗
$8MSeries AAug 2022 · 2 sources
Javelin Venture Partners (lead), Alumni Ventures, Great Oaks, Growth Warrior Capital, Social Leverage, Struck Capital, V1VC
Source ↗
Undisclosed amountseed fundingJan 2022
Source ↗
Undisclosed amountseed fundingDec 2021
Graph Ventures, Long Journey Ventures, MaC VC, Pear Accelerator, Ulu Ventures
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 2

by search overlap

Tandem Diabetes Care, Inc.32 shared keywordsTandem Diabetes manufactures infusion sets—tubing systems with subcutaneous delivery sites—designed for use with insulin pumps to manage diabetes. The product line includes several models (AutoSoft XC, AutoSoft 30, VariSoft, TruSteel) with varying insertion angles and tubing lengths.

Diabetes25 shared keywordsA nonprofit organization that provides educational resources and information about prediabetes, including prevention strategies and lifestyle management for Americans at risk of developing type 2 diabetes.

Companies competing with Sequel for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Sequel Raises $8M in Series A Fundingfinsmes.com · Sep 2022

Sequel Announces $8 Million Series A Funding to Power the Next Generation of Online Video Communitiesprweb.com · Aug 2022

Virtual events startup Sequel just raised $8 million from MasterClass investor Javelin Venture Partnersbusinessinsider.com · Aug 2022

US' Sequel raises $5 million in seed funding for re-engineered tampons - Fibre2Fashionfibre2fashion.com · Jan 2022

Sequel Launches with $5M in Seed Funding to Take Its Patented, Leakage-Preventing Tampon to Market | Femtech Insiderfemtechinsider.com · Dec 2021

Frequently asked questions

What does Sequel do?: Sequel Med Tech develops wearable insulin delivery devices and precise drug delivery technology for people with diabetes and others, building on the legacy of the insulin pump. The company serves people with type 1 diabetes and healthcare providers, with plans to support drug delivery beyond diabetes.
Who are Sequel's investors?: Sequel's investors include FemHealth Ventures, Alumni Ventures, Graph Ventures, Growth Warrior Capital, Javelin Venture Partners, Long Journey Ventures, Social Leverage, Struck Capital and 1 more.
How much funding has Sequel raised?: Sequel has disclosed $8M raised across 1 of its 4 known rounds.
Where is Sequel headquartered?: Sequel is headquartered in Manchester, US.